These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients. Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H. Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855 [Abstract] [Full Text] [Related]
3. Parameters of the classical complement pathway predict disease severity in hereditary angioedema. Csuka D, Füst G, Farkas H, Varga L. Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570 [Abstract] [Full Text] [Related]
4. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Lunn ML, Santos CB, Craig TJ. Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110 [Abstract] [Full Text] [Related]
7. Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema. Varga L, Füst G, Csuka D, Farkas H. Mol Immunol; 2011 Jan; 48(4):572-6. PubMed ID: 21111483 [Abstract] [Full Text] [Related]